December 20, 2021 – McKesson Corporation announced it has entered into an agreement to sell its Austrian business to Quadrifolia Management GmbH.
The transaction includes the sale of McKesson Austria’s Herba Chemosan Apotheker-AG, together with Sanova Pharma GesmbH.
Quadrifolia will be conducting a management buyout which will see the existing management of the Austrian business buy all of the Herba Chemosan Apotheker-AG and Sanova Pharma GesmbH, backed by Invest AG. Invest AG has a solid track record of backing businesses in Austria over 25 years and will provide the new owners with further strength to fuel innovation and competition.
“Today’s transaction marks another milestone in advancing McKesson’s intent to streamline the portfolio and prioritize investments in areas where we have deep expertise and are central to our long-term growth strategy. We are making good progress in executing our strategy to exit Europe and continue to evaluate suitable exit alternatives for our businesses in Norway and Denmark” said Brian Tyler, chief executive officer, McKesson.
The transaction is expected to close in fiscal 2022, subject to customary closing conditions, including receipt of required regulatory approvals.